Smile, it's the holiday season

Article

It's almost the end of the year. The days are getting shorter, the nights are getting longer and the climate around the majority of countries in Europe is dipping to very unpleasant levels.

I'm not sure whether SAD is a condition that you are familiar with but I know, certainly in the UK, it's around this time of year that people start complaining that they are suffering from Seasonal Affective Disorder, hence SAD. It is for this reason that they spend their days feeling low with pretty much little energy to do anything apart from to sit in front of the television with a big blanket and lots of comfort food. This mood tends to be maintained by the sufferer throughout the days and months leading up to spring (apart from during the festive holiday season when alcohol generally induces a temporary change in mood).

Now, apparently this is a clinically proven condition and I certainly cannot say whether it is or it isn't. I'm definitely guilty of feeling a little depressed on occasion during the winter months, particularly because, like most of you, I drive to work in the dark and then back home in the dark. There are days when I wish I could stay at home and hibernate until the rain clears and the sun shines. Still, one thing that always makes me happy is reflecting on what an incredible year this has been for us at Ophthalmology Times Europe.

I would like to thank you all so much for making this year a professionally and personally rewarding and a very enjoyable one for me.

For now, I would like to wish you all a wonderful vacation and I look forward to seeing you in 2007.

With very best wishes,
Fedra PavlouEditor

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.